CoMentis, Inc. has its headquarters in South San Francisco. The company is engaged in the discovery and development of small- molecule drugs to treat CNS disorders. For more information about CoMentis, please visit the Company's website at http://www.comentis.com
| Website | http://comentis.com |
| Revenue | $7.1 million |
| Funding | $93.5 million |
| Employees | 21 (14 on RocketReach) |
| Founded | 2006 |
| Address | 400 Oyster Point Blvd. Suite 226, South San Francisco, California 94080, US |
| Phone | +1 650-869-7600 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+19 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Drug Discovery, Drug discovery, Manufacturing, Pharmaceuticals, Drug development, CNS |
| Competitors | Cerebral, Talkspace, Regain, MDLIVE, by Evernorth, Amwell, PsychiatryOnline, Zencare.co, Woebot Health, Lemonaid Health, Ginger +24 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 87 Companies, SIC Code 873 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies |
Looking for a particular CoMentis, Inc. employee's phone or email?
The CoMentis, Inc. annual revenue was $7.1 million in 2026.
Steffi Kieffer is the Co-Founder and CPO of CoMentis, Inc..
14 people are employed at CoMentis, Inc..
CoMentis, Inc. is based in South San Francisco, California.
The NAICS codes for CoMentis, Inc. are [32541, 325, 3254, 541, 54, 32].
The SIC codes for CoMentis, Inc. are [2834, 283, 87, 873, 28].